|
Andhra Med Tech Zone Gets Formal
Registration To Set Up Asia’s First Dedicated Medical Devices Park
Andhra Med Tech Zone (AMTZ) - company established under government of Andhra
Pradesh has finally received formal registration which will kick start
establishing Asia’s first dedicated medical device park in an area of 226 acres
at Visakhapatnam in Andhra Pradesh.
AMTZ has cleared a major milestone- with the release of RFP for selection
project consultancy firm for preparing a Detailed Project Report (DPR).
Andhra Med Tech Zone Ltd. (AMTZ) in its marathon target to be the first of its
kind medical equipment manufacturing hub, has cleared another major milestone-
with the
release of RFP for selection project consultancy firm for preparing a Detailed
Project Report (DPR). The RFP for DPR agency was released on 3rd of June and a
pre-bid meeting with Industrial Partners was held on 17th June at Visakhapatnam.
While champions in industrial designing and infra-tech development are expected
to participate in the preparation of DRP for the prestigious project, no effort
would be spared in getting technical excellence to design and implement the
project- said Dr. Jitendar Sharma, the Chief Executive Office of AMTZ Ltd.
Andhra Pradesh health department has formally taken over 226 acres of land to
set up Asia’s first dedicated medical device park at Visakhapatnam. AMTZ is
proposed to
have in-house high investment scientific facilities that would help
manufacturers reduce the cost of manufacturing and is first of its kind in Asia
as it aims to flourish as a hub of medical device manufacturing, putting India
on the global map of high end medical equipment production.
The park will provide for modern state of art common facilities such as
specialized laboratories, warehousing, testing centre apart from 100 to 150
independent
manufacturing units, each in a built-in ready to use area of 0.5 to 1 acre each.
A park with in-house high investment scientific facilities would help
manufacturers reduce the cost of manufacturing by more than 40 per cent to 50
per cent.
Indian medical device industry is worth over Rs. 60,000 crore and country’s
humongous import bill for this segment amounts to over Rs. 23,000 crore while
export amounts to only over Rs. 7,000 crore. India’s import dependency on
high-end medical devices is over 80 per cent and 60 per cent to 70 per cent for
other devices. And this is where the dedicated medical device park would be of
great value - reducing humongous import dependency, increasing export while
generating wealth and employment within.
(Ref.:
http://www.pharmabiz.com/NewsDetails.aspx?aid=94934&sid=1
http://ealth.economictimes.indiatimes.com/news/medical-devices/amtz-opensdetailed-project-report-opportunity-forglobal-cos-/52815286)
Gujarat Govt Allocates Land For Setting
Up Medical Device Park At Sanand
Subsequent to Union minister of chemicals and fertilisers
Ananth Kumar announcement for setting up medical devices and pharma parks in
Gujarat, Gujarat government has finally identified and allocated the land for
the same at Sanand near Ahmedabad.
Detailed Project Report (DPR) has also been submitted and a
favourable response has been awaited on the same from the Centre, informed an
official associated with the development.
Gujarat Food and Drug Control Administration (FDCA)
commissioner Dr H G Koshia said, “A medical device park is also very much
relevant for Gujarat as the state has the largest number of 135 licensed medical
device companies as against 240 in the entire country which are nurtured by
Gujarat FDCA with an exemplary approach and has received recognition in the
country.”
He explained government’s plan to set up medical device parks
will bring about quality, compliance and provide cost effectiveness in the
industry by providing infrastructure to boost medical device manufacturing in
India.
The creation of manufacturing park for medical devices is the
need of the hour as medical devices manufacturing requires certain high
investment facilities which are too capital intensive for individual
manufacturers to invest upon.
Currently, due to lack of such centrally located common
facilities, manufacturers do not undertake production of technologies and
therefore send their products abroad for process up-gradation and value
addition.
This will also help facilitate to create an ecosystem for
manufacturing of high end medical device manufacturing aimed at import
substitution and export opportunities and would be a major boost to SMEs.
(Ref.:
http://www.pharmabiz.com/NewsDetails.aspx?aid=95558&sid=1)
|
